A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
No Thumbnail Available
Authors
Minion, L. E.
Bai, J.
Monk, B. J.
Robin Keller, L.
Ramez, E. N.
Forde, G. K.
Chan, J. K.
Tewari, K. S.
Issue Date
2015
Volume
Issue
Type
Journal Article
Language
eng_US
Keywords
Alternative Title
Abstract
Description
Citation
Minion, L. E.; Bai, J.; Monk, B. J.; Robin Keller, L.; Ramez, E. N.; Forde, G. K.; Chan, J. K.; Tewari, K. S. (2015). A Markov Model to Evaluate Cost-Effectiveness of Antiangiogenesis Therapy using Bevacizumab in Advanced Cervical Cancer. Gynecologic oncology, 2015 March 10 doi: http://doi.org/10.1016/j.ygyno.2015.02.027
Publisher
Elsevier Inc
License
Journal
Volume
Issue
PubMed ID
DOI
Identifier
Additional link
ISSN
1095-6859
0090-8258
0090-8258